An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line

Código QR

An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line

Xinzhe Yu,1,* Yang Di,2,* Chao Xie,3 Yunlong Song,4 Hang He,2 Hengchao Li,1 Xinming Pu,5 Weiyue Lu,3 Deliang Fu,2 Chen Jin1 1Pancreatic Surgery Department, Huashan Hospital, 2Pancreatic Disease Institute, Fudan University, 3School of Pharmacy & Key Laboratory of Smart Drug Delivery, Fudan U...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yu XZ, Di Y, Xie C, Song YL, He H, Li HC, Pu XM, Lu WY, Fu DL, Jin C
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/ed521855b4b640ffad646a35295c3c34
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression
por: Guo ZY, et al.
Publicado: (2018)

Preparation of folic acid-conjugated, doxorubicin-loaded, magnetic bovine serum albumin nanospheres and their antitumor effects in vitro and in vivo
por: Yang R, et al.
Publicado: (2014)

Study of the combined treatment of lung cancer using gene-loaded immunomagnetic albumin nanospheres in vitro and in vivo
por: Zhang H, et al.
Publicado: (2016)

Triple-functional albumin-based nanoparticles for combined chemotherapy and photodynamic therapy of pancreatic cancer with lymphatic metastases
por: Yu XZ, et al.
Publicado: (2017)

Folic acid-modified ginsenoside Rg5-loaded bovine serum albumin nanoparticles for targeted cancer therapy in vitro and in vivo
por: Dong Y, et al.
Publicado: (2019)

Gemcitabine-loaded liposomes: rationale, potentialities and future perspectives
por: Federico C, et al.
Publicado: (2012)

Design and formulation of a topical hydrogel integrating lemongrass-loaded nanosponges with an enhanced antifungal effect: in vitro/in vivo evaluation
por: Aldawsari HM, et al.
Publicado: (2015)

Inhibition of SIRT1 combined with gemcitabine therapy for pancreatic carcinoma
por: Gong DJ, et al.
Publicado: (2013)

In vitro and in vivo targeting imaging of pancreatic cancer using a Fe3O4@SiO2 nanoprobe modified with anti-mesothelin antibody
por: Liu F, et al.
Publicado: (2016)

Selective ex-vivo photothermal ablation of human pancreatic cancer with albumin functionalized multiwalled carbon nanotubes
por: Mocan L, et al.
Publicado: (2011)

Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
por: Ru Chen, et al.
Publicado: (2017)

Polymer coated gold nanoshells for combinational photochemotherapy of pancreatic cancer with gemcitabine
por: Mina Emamzadeh, et al.
Publicado: (2021)

Effect of particle size on oral absorption of carvedilol nanosuspensions: in vitro and in vivo evaluation
por: Liu DD, et al.
Publicado: (2015)

Improved antibacterial activity and biocompatibility on vancomycin-loaded TiO2 nanotubes: in vivo and in vitro studies
por: Zhang HZ, et al.
Publicado: (2013)

Preparation and in vitro/in vivo characterization of enteric-coated nanoparticles loaded with the antihypertensive peptide VLPVPR
por: Sun HY, et al.
Publicado: (2014)

Undetactable levels of genotoxicity of SiO2 nanoparticles in in vitro and in vivo tests [Erratum]
por: Kwon JY, et al.
Publicado: (2015)

DUSP1 is a novel target for enhancing pancreatic cancer cell sensitivity to gemcitabine.
por: Fang Liu, et al.
Publicado: (2014)

In vitro release and in vitro&ndash;in vivo correlation for silybin meglumine incorporated into hollow-type mesoporous silica nanoparticles
por: Cao X, et al.
Publicado: (2012)

Synthesis, characterization, and in vitro evaluation of curcumin-loaded albumin nanoparticles surface-functionalized with glycyrrhetinic acid
por: Li J, et al.
Publicado: (2015)

GEM-loaded magnetic albumin nanospheres modified with cetuximab for simultaneous targeting, magnetic resonance imaging, and double-targeted thermochemotherapy of pancreatic cancer cells
por: Wang L, et al.
Publicado: (2015)

Long-lasting bactericidal activity through selective physical puncture and controlled ions release of polydopamine and silver nanoparticles–loaded TiO2 nanorods in vitro and in vivo
por: Guan M, et al.
Publicado: (2019)

Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles
por: Dongmei Zhao, et al.
Publicado: (2010)

Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination therapy.
por: Genta Ito, et al.
Publicado: (2021)

Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.
por: Daniel A Monti, et al.
Publicado: (2012)

Tuning gut microbiota through a probiotic blend in gemcitabine‐treated pancreatic cancer xenografted mice
por: Concetta Panebianco, et al.
Publicado: (2021)

A 14-gene gemcitabine resistance gene signature is significantly associated with the prognosis of pancreatic cancer patients
por: Xing Wei, et al.
Publicado: (2021)

OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma
por: Jinsheng Ding, et al.
Publicado: (2021)

hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA
por: Karen Aughton, et al.
Publicado: (2021)

Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy
por: Guizhi Zhu, et al.
Publicado: (2017)

Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter, single-arm, open-label, phase 2 trial
por: Gunn Huh, et al.
Publicado: (2021)

A toxic organic solvent-free technology for the preparation of PEGylated paclitaxel nanosuspension based on human serum albumin for effective cancer therapy
por: Yin TJ, et al.
Publicado: (2015)

Efficacy and mechanism of tanshinone IIA liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro
por: Qin F, et al.
Publicado: (2015)

Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells.
por: Tomotaka Kato, et al.
Publicado: (2021)

The synergistic tumor growth-inhibitory effect of probiotic Lactobacillus on transgenic mouse model of pancreatic cancer treated with gemcitabine
por: Shan-Ming Chen, et al.
Publicado: (2020)

Lower irritation microemulsion-based rotigotine gel: formulation optimization and in vitro and in vivo studies
por: Wang Z, et al.
Publicado: (2015)

Isoniazid—Loaded Albumin Nanoparticles: Taguchi Optimization Method
por: Yerkeblan Tazhbayev, et al.
Publicado: (2021)

Albumin-encapsulated Nanoparticles of Naproxen Platinum(IV) Complexes with Inflammation Inhibitory Competence Displaying Effective Antitumor Activities in vitro and in vivo
por: Li L, et al.
Publicado: (2021)

Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation
por: Sanyuan Hu, et al.
Publicado: (2010)

Silver-loaded nanotubular structures enhanced bactericidal efficiency of antibiotics with synergistic effect in vitro and in vivo
por: Xu N, et al.
Publicado: (2017)

Bio Micro-Nano Technologies of Antioxidants Optimised Their Pharmacological and Cellular Effects, ex vivo, in Pancreatic β-Cells
por: Mooranian A, et al.
Publicado: (2020)